Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96LW4
UPID:
PRIPO_HUMAN
Alternative names:
Coiled-coil domain-containing protein 111
Alternative UPACC:
Q96LW4; A0A0A0MTC0; D3DP55; D6RDM1; Q5HYJ9
Background:
The DNA-directed primase/polymerase protein, also known as Coiled-coil domain-containing protein 111, plays a crucial role in DNA replication and repair. It facilitates the bypass of replication-stalling lesions and is essential for both mitochondrial and nuclear DNA synthesis. This protein's ability to tolerate DNA damage lesions and reinitiate stalled replication forks underscores its importance in maintaining genomic stability.
Therapeutic significance:
Linked to Myopia 22, autosomal dominant, this protein's mutation highlights its clinical relevance. Understanding the role of DNA-directed primase/polymerase protein could open doors to potential therapeutic strategies, especially in enhancing DNA repair mechanisms in genetic disorders and improving outcomes in cancer therapy.